DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and-resistant human colon carcinoma cells
- 1 January 1990
- journal article
- conference paper
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 25 (6) , 430-434
- https://doi.org/10.1007/bf00686054
Abstract
The effects of mitoxantrone (Mx) and doxorubicin (Dx) on cytotoxicity and DNA damage as assayed by alkaline elution were studied in two human colon adenocarcinoma cell lines sensitive (LoVo) and resistant (LoVo/Dx) to doxorubicin. Mx was more cytotoxic than Dx to LoVo cells and was partially cross-resistant in LoVo/Dx. In LoVo cells, Mx produced about 5 times more DNA single-strand breaks (DNA-SSB) than Dx, but both drugs caused an equal number of DNA double-strand breaks (DNA-DSB). In LoVo/Dx cells, the number of DNA-DSB was very low for both Dx and Mx, but DNA-SSB were about 20 times higher for Mx. In LoVo cells, the number of DNA-DSB and protein-associated SSB were similar at equitoxic concentrations. For LoVo/Dx, the partial cross-resistance of Mx might be explained by the much higher number of DNA-SSB produced by this drug.This publication has 22 references indexed in Scilit:
- Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo)Biochemical Pharmacology, 1989
- Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant sublineBiochemical Pharmacology, 1988
- DIRECT RELATION OF DNA LESIONS IN MULTIDRUG-RESISTANT HUMAN MYELOMA CELLS TO INTRACELLULAR DOXORUBICIN CONCENTRATION1988
- Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cellsBiochemical Pharmacology, 1988
- Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitroCancer Chemotherapy and Pharmacology, 1985
- Design of Anticancer Drugs Using Modeling TechniquesAnnals of the New York Academy of Sciences, 1985
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984
- Relationship between cytotoxicity and DNA damage in mammalian cells treated with anthracenedione derivativesChemico-Biological Interactions, 1983
- Anthracenedione activation by nadph-cytochrome p-450 reductase; Comparison with anthracyclinesBiochemical Pharmacology, 1981
- Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line.1976